-
Analyst Opinions
NewWealth Management Trends and Themes in 2024
This report informs wealth managers and their strategy teams of the key developments emerging across the industry and how best to respond to these changes. The report examines in detail key areas such as the crypto hype, HNW asset allocation strategies, profitability, and ESG, with analysis supported by findings from GlobalData’s propriety surveys of wealth managers and investors. 2024 promises to be another challenging year. Economic growth remains slow, geopolitical tensions are mounting, and inflation remains stubbornly high in key...
-
Analyst Opinions
NewBroker Distribution Insight 2024 – Which Insurers Lead the Way?
This report explores which insurers can be considered market leaders from the point of view of commercial brokers. The report looks at factors that brokers find most important when selecting an insurer with which to place business, analyzing how this has changed over the course of the cost-of-living crisis. Across 11 different aspects questioned, brokers select the insurer they consider to be best in class. The four leading insurers are discussed individually, as well as each separate category. The top...
-
Analyst Opinions
NewTop Trends and Demand Spaces in Plant-Based Meat and Seafood Alternatives​ – Industry Insights
This report is part of a series on the top trends and key demand spaces for consumers sectors to focus on in 2024. This report explains how and why these trends are happening using GlobalData's TrendSights and demand space analytical frameworks. The report identifies the consumer sentiment, market development, innovation landscape, the issues facing plant-based meat and seafood, and brand actions happening within each trend. The plant-based market finds itself at a crossroads in 2024 as it faces consolidation and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NC-410 in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NC-410 in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NC-410 in Cervical Cancer Drug Details: NC-410 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NC-410 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NC-410 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NC-410 in Gastric Cancer Drug Details: NC-410 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NC-410 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NC-410 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NC-410 in Endometrial Cancer Drug Details: NC-410 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NC-410 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NC-410 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NC-410 in Colorectal Cancer Drug Details: NC-410 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ALG.APV-527 in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ALG.APV-527 in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ALG.APV-527 in Head And Neck Squamous...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ALG.APV-527 in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ALG.APV-527 in Metastatic Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ALG.APV-527 in Metastatic Pancreatic Cancer Drug Details: ALG.APV-527 is under...